ResearchAndMarkets.com added separate reports on the global single-use assemblies and reusable bioreactors markets, describing continued investment in flexible, controlled and scalable biopharmaceutical production. The single-use assemblies market is estimated at USD 6.0 billion to USD 9.5 billion in 2026 and is projected to grow approximately 14.5% to 17.5% annually through 2031, while the reusable bioreactors market is forecast to expand from USD 9.6 billion in 2025 to USD 24.7 billion by 2035 at a 9.9% compound annual growth rate. Single-use systems can reduce contamination risk, cleaning requirements, water consumption, turnaround times and initial capital expenditure, whereas reusable bioreactors support durable, repeatable, high-volume production with integrated automation, monitoring, cleaning and sterilization. Biologics, vaccines, biosimilars, cell and gene therapies, personalized medicine and bioprocessing technology are common demand drivers, although the reports identify extractables and leachables, material compatibility, plastic waste, sterilization capacity, supply-chain concentration and single-use capacity as challenges.